from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2654c/-

LFCtreatmentdescriptionclass of inhibitor

-0.325

Amikacinug/mL Amikacintranslation

-0.018

Cap5-10ug/mL Capreomycintranslation

0.828

Rox10-50 ug/mL Roxithromycintranslation

-0.534

SM2-5 ug/mL Streptomycintranslation

0.201

Tet5-10 ug/mL Tetracyclinetranslation

0.600

Rif0.2-5ug/mL Rifampicintranscription

-0.635

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.419

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.779

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.445

CPZ10-50 ug/mL Chlorpromazinerespiration

2.275

Clofazimine10-13 ug/mL Clofaziminerespiration

0.464

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.318

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.162

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.059

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.146

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.353

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.068

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.547

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.757

KCN5-20 ug/mL Potassium cyaniderespiration

0.193

NaN30.2-2 mM Sodium aziderespiration

-0.421

Nigericin50 uM Nigericinrespiration

-0.171

TRC10-150 ug/mL Triclosanrespiration

2.325

TRZ10-25 ug/mL Thioridazinerespiration

0.652

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.306

menadione6-10 ug/mL Menadionerespiration

-0.536

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.384

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.148

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.248

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.640

NRP_1Non-replicating persistence stage 1dosRassociated

-0.431

Amp0.2mg/mL AmpicillincellWall

0.129

Cephalexin20-100 ug/mL CephalexincellWall

-0.659

Cerulenin0.32-5 ug/mL CerulenincellWall

0.252

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.299

EMB10-20 ug/mL EthambutolcellWall

-0.543

Eta12-40 ug/mL EthionamidecellWall

-1.126

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.550

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.521

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.833

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.172

BZA0.12 mg/mL BenzamidearomaticAmides

0.026

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.187

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.010

H2O24 mM hydrogen peroxideDNAdamaging

-0.350

Levo10 ug/mL LevofloxacinDNAdamaging

-0.537

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.148

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.162

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.362

UVUV-irradiationDNAdamaging

0.106

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.707

Antimycin12.5-50 ug/mL Antimycin A?

-0.102

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.428

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.528

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.290

PA8240.2-2 ug/mL PA-824?

0.138

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.388

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.522

Verapamil50 uM Verapamil?

-0.802

mercaptoethanol2 mM 2-Mercaptoethanol?

1.293

methoxatin10-20 ug/mL Methoxatin?